The Enterprise Value as of December 2025 (TTM) for TransCode Therapeutics, Inc. (RNAZ) is -2827998091.00

According to TransCode Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -2827998091.00. This represents a change of 301.24% compared to the average of -704812094.47 of the last 4 quarters.

TransCode Therapeutics, Inc. (RNAZ) Historical Enterprise Value (quarterly & annually)

How has RNAZ Enterprise Value performed in the past?

The mean historical Enterprise Value of TransCode Therapeutics, Inc. over the last ten years is 8.49B. The current -2827998091.00 Enterprise Value has changed -3432.08% with respect to the historical average. Over the past ten years (40 quarters), RNAZ's Enterprise Value was at its highest in in the June 2021 quarter at 40.95B. The Enterprise Value was at its lowest in in the September 2025 quarter at -2826953907.75.

TransCode Therapeutics, Inc. (RNAZ) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of TransCode Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

TransCode Therapeutics, Inc. (RNAZ) Average Enterprise Value

How has RNAZ Enterprise Value performed in the past?

The current Enterprise Value of TransCode Therapeutics, Inc. (RNAZ) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

TransCode Therapeutics, Inc. (RNAZ) Enterprise Value vs. Peers

How is RNAZ’s Enterprise Value compared to its peers?

TransCode Therapeutics, Inc.’s Enterprise Value is less than IN8bio, Inc. (702.60K), less than Lyra Therapeutics, Inc. (10.68M), less than Aptevo Therapeutics Inc. (66.93M), less than Galecto, Inc. (22.83M), less than Phio Pharmaceuticals Corp. (3.83M), less than HCW Biologics Inc. (10.10M), less than Kiora Pharmaceuticals, Inc. (7.29M), less than Aprea Therapeutics, Inc. (-10063033.00), less than Bolt Biotherapeutics, Inc. (16.02M), greater than Acurx Pharmaceuticals, Inc. (-5901286277.00),

Build a custom stock screener for TransCode Therapeutics, Inc. (RNAZ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like TransCode Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

TransCode Therapeutics, Inc. (RNAZ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like TransCode Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.